Broadly neutralizing antibodies that target epitopes of haemagglutinin on the influenza virus
have the potential to provide near universal protection against influenza virus infection 1 . …

Influenza is a leading cause of death in the elderly, and the vaccine protects only a fraction
of this population. A key aspect of antibody-mediated anti-influenza virus immunity is …

Humans are repeatedly exposed to variants of influenza virus throughout their lifetime. As a
result, preexisting influenza-specific memory B cells can dominate the response after …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently causing a
global pandemic. The antigen specificity of the antibody response mounted against this novel …

Polyreactivity is the ability of a single antibody to bind to multiple molecularly distinct antigens
and is a common feature of antibodies induced upon pathogen exposure. However, little is …

Dissecting the evolution of memory B cells (MBCs) against SARS-CoV-2 is critical for
understanding antibody recall upon secondary exposure. Here, we used single-cell sequencing to …

Broadly neutralizing antibodies are critical for protection against both drifted and shifted
influenza viruses. Here, we reveal that first exposure to the 2009 pandemic H1N1 influenza virus …

Background Convalescent plasma therapy for COVID‐19 relies on transfer of anti‐viral
antibody from donors to recipients via plasma transfusion. The relationship between clinical …

Antibodies are critical for providing protection against influenza virus infections. However,
protective humoral immunity against influenza viruses is limited by the antigenic drift and shift …

Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have
arisen that exhibit increased viral transmissibility and partial evasion of immunity induced by …